SSX4B anticorps (Middle Region)

N° du produit ABIN2784178

Cet anticorps Lapin Polyclonal détecte spécifiquement SSX4B dans WB. Il présente une réactivité envers Humain.

Aperçu rapide pour SSX4B anticorps (Middle Region) (ABIN2784178)

Antigène: SSX4B (Synovial Sarcoma, X Breakpoint 4B (SSX4B))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SSX4B est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-SSX4B anticorps

Épitope: Middle Region

Séquence: MRSKRAADFH GNDFGNDRNH RNQVERPQMT FGSLQRIFPK IMPKKPAEEE

Homologie: Human: 100%

Attributs du produit: This is a rabbit polyclonal antibody against SSX4B. It was validated on Western Blot using a cell lysate as a positive control.

Purification: Affinity Purified

Immunogène: The immunogen is a synthetic peptide directed towards the middle region of human SSX4B

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator.

Commentaires:

Antigen size: 188 AA

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Détails sur SSX4B

Antigène: SSX4B (Synovial Sarcoma, X Breakpoint 4B (SSX4B))

Autre désignation: SSX4B

Sujet: The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4B, represents the more centromeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.
Alias Symbols: SSX4, CT5.4
Protein Interaction Partner: HIF1A,
Protein Size: 188

Poids moléculaire: 22 kDa

ID gène: 548313

NCBI Accession: NM_001034832, NP_001030004

UniProt: O60224